Unfabled, a leading destination for women’s health and wellbeing, announced a €1.5 million round to address the gender health gap, taking its total funding to €1.8 million. The round will be used to expand the consumer-facing platform as well as develop its in-house data science, a core element of its B2B offering.
Prominent investors joined the seed round including Morgan Stanley, Exceptional Ventures, Atomico Angels, Founders Factory, Chai Ventures, SyndicateRoom, and 3 Sisters Ventures. Angel investors, the majority of them women, also joined from across technology and healthcare. They include Maya Ghosn (a scout for Sequoia) Shefali Roy (Apple, TrueLayer), Elaine Groenestein (first angel at Elvie), and Fiona Pathiraja (Healthcare investor and philanthropist).
Founded in 2021 by Hannah Samano (ex-Unilever, Kasha), Unfabled is a data-driven health platform that delivers curated and personalised solutions for women. After answering a series of questions about their hormonal and health priorities, Unfabled provides users with a curated selection of trusted and effective products to support their needs. Over 300,000 people are using Unfabled to discover effective treatments for a range of conditions, from menstrual cramps to pregnancy and menopause.
Unfabled’s market intelligence platform, the B2B element of the product, provides crucial insights into consumer behaviour for healthcare and businesses to drive future advancements in women’s health.
Hannah Samano, Founder and CEO of Unfabled, said: “Despite 90% of the UK’s 33.8 million female population experiencing monthly hormonal symptoms, women’s health has for too long been fragmented and underserved. Unfabled has already empowered thousands of women to find effective treatments for common, yet hugely disruptive, hormonal and reproductive conditions like PMS, Polycystic Ovary Syndrome (PCOS), endometriosis and menopause.”
According to Samano, a major cause of the gender health gap is the lack of sex-aggregated data which causes a lack of insight and understanding across women’s health. That is why they are building the most user-friendly platform possible while also filling the massive gap that continues to exist in health-related data. The more they understand about female health, the more laser-focused they can become on improving it.
According to a 2024 McKinsey report, the women’s health market is poised to hit $1 trillion by 2027. The same report highlights that just addressing pre-menstrual syndrome (PMS), a condition that affects 90% of those who menstruate, could contribute a remarkable $115 billion to the global economy.
Sanghamitra Karra, Managing Director and EMEA Head of the Morgan Stanley Inclusive Ventures Group, added: “We have been impressed both by Unfabled’s platform and their reach, partnering with leading brands in the space. With an engaged community of 50,000 women and educational content on women’s health reaching 40M+ views, Hannah and the team’s proven organic-driven approach has enabled Unfabled to grow impressively since 2021.”
Matt Cooper, Co-Founder and Executive Chairman at Exceptional Ventures, also commented: “When investing in a company, our primary focus is finding businesses that match our vision of helping people to live happier, healthier and longer lives. At the same time, we’re looking for the most talented entrepreneurs capable of delivering on that vision. Unfabled was a clear fit on both points, we were instantly taken by its mission to support women’s hormonal health. Unabled’s data-led platform empowers women to discover products and services often overlooked by mainstream healthcare and provides a consumer-friendly solution to a long-standing problem that affects so many lives. Hannah is a brilliant founder whose intellect, passion and drive for her business and its mission were irresistible.”
